Power Law company profile

Janux Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2017 · IPO 2021 Unicorn

Developing unique immunotherapies that generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue

Revenue

$10.0M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Janux Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage

Avalon Ventures

OrbiMed

Bregua Corporation

Correlation Ventures

RA Capital Management

Series B+ 7 investors entered at this stage

EcoR1 Capital

Hartford HealthCare Endowment

BVF Partners

Janus Henderson Investors

Logos Capital

Citadel

Samsara BioCapital

Global footprint

Where Janux Therapeutics has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States80.9%

🇬🇧 United Kingdom9.1%

🇯🇵 Japan6.4%

🇮🇳 India0%

Top 4 markets shown

Patent intelligence

$2M patent portfolio · 29 active families

Estimated portfolio value

$2M

947.3× smaller than top peer Ablynx ($2B)

29 active patent families

Where Janux Therapeutics innovates Molecular biologyPharmaceutical drugAntibody targetingEffector cellNucleic acid

Where Janux Therapeutics concentrates vs peers

Each axis is a top-10 topic across Janux Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Janux Therapeutics

An AI-synthesized read of the highest-engagement posts about Janux Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Janux Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles